Available Technologies
# of Displayed Technologies: 2 / 2
Biomimetic vitreous substitute with ocular drug delivery
TS-044490 — Methods and compositions for an antioxidant releasing hydrogel vitreous substitute
The vitreous humor is a fragile, transparent tissue between the lens and the retina of the eye that maintains the shape of the eye, acts as a shock absorber, and enables nutrient diffusion to ocular tissues. The vitreous also plays a key role in oxygen homeostasis. Over time, the vitreous degrades…
- College: College of Engineering (COE)
- Inventors: Reilly, Katelyn; Reilly, Matthew; Tram, Nguyen "Archie"
- Licensing Officer: Schworer, Adam
Sustained Release Microparticles for the Treatment of Ocular Diseases
TS-038312 — A novel, intravitreal microparticle injection capable of controlled-release of protein therapies (including anti-VEGF) for tunable periods of 6-12 months after injection for the treatment of age-related macular degeneration.
Age-related macular degeneration (AMD) is the leading cause of blindness in individuals 65 and older and is the third leading cause of blindness worldwide. Wet AMD is characterized by abnormal growth of leaky blood vessels leading to damage to the macula of the retina resulting in vision loss and …
- College: College of Engineering (COE)
- Inventors: Jiang, Pengfei; Ohr, Matthew; Reilly, Katelyn
- Licensing Officer: Schworer, Adam
